ARQT
Price
$34.05
Change
+$2.05 (+6.41%)
Updated
Nov 4 closing price
Capitalization
4.28B
117 days until earnings call
Intraday BUY SELL Signals
ENGN
Price
$1.72
Change
+$0.10 (+6.17%)
Updated
Nov 4 closing price
Capitalization
115.27M
53 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARQT vs ENGN

ARQT vs ENGN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ARQT vs. ENGN commentary
Nov 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARQT is a Hold and ENGN is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ARQT with price predictions
Nov 04, 2026

ARQT's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for ARQT turned positive on October 13, 2026. Looking at past instances where ARQT's MACD turned positive, the stock continued to rise in 41 of 44 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on ARQT as a result. In 75 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 88%.

ARQT moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ARQT crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +8.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARQT advanced for three days, in 249 of 293 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

The Aroon Indicator entered an Uptrend today. In 198 of 222 cases where ARQT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 89%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 59 of 69 cases where ARQT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARQT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

ARQT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. ARQT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 54 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARQT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (19.403) is normal, around the industry mean (2.904). ARQT's P/E Ratio (154.773) is considerably higher than the industry average of (-0.738). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.314) among similar stocks. P/S Ratio (7.435) is also within normal values, averaging (440.869).

A.I.Advisor
a Summary for ENGN with price predictions
Nov 04, 2026

Momentum Indicator for ENGN turns positive, indicating new upward trend

ENGN saw its Momentum Indicator move above the 0 level on November 04, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 54 similar instances where the indicator turned positive. In 50 of the 54 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ENGN's RSI Indicator exited the oversold zone, 19 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 33 of 38 cases where ENGN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.

The Moving Average Convergence Divergence (MACD) for ENGN just turned positive on November 04, 2026. Looking at past instances where ENGN's MACD turned positive, the stock continued to rise in 23 of 27 cases over the following month. The odds of a continued upward trend are 85%.

Following a +18.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where ENGN advanced for three days, in 129 of 152 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

ENGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

ENGN moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ENGN crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 78%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

The Aroon Indicator for ENGN entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.501) is normal, around the industry mean (2.904). P/E Ratio (-0.831) is within average values for comparable stocks, (-0.738). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.314) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 44 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. ENGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
ARQT: Fundamental Ratings
ARQT
OUTLOOK RATING
1..100
42
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
70
SMR RATING
1..100
54
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
21
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARQTENGN
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 14 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
COMPARISON
Comparison
Nov 05, 2026
Stock price -- (ARQT: $34.05 vs. ENGN: $1.72)
Brand notoriety: ARQT and ENGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARQT: 87% vs. ENGN: 188%
Market capitalization -- ARQT: $4.28B vs. ENGN: $115.27M
ARQT [@Biotechnology] is valued at $4.28B. ENGN’s [@Biotechnology] market capitalization is $115.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $139.16B. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARQT’s FA Score shows that 1 FA rating(s) are green while ENGN’s FA Score has 0 green FA rating(s).

  • ARQT’s FA Score: 1 green, 4 red.
  • ENGN’s FA Score: 0 green, 5 red.
According to our system of comparison, ARQT is a better buy in the long-term than ENGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARQT’s TA Score shows that 6 TA indicator(s) are bullish while ENGN’s TA Score has 6 bullish TA indicator(s).

  • ARQT’s TA Score: 6 bullish, 4 bearish.
  • ENGN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ARQT and ENGN are a good buy in the short-term.

Price Growth

ARQT (@Biotechnology) experienced а +8.27% price change this week, while ENGN (@Biotechnology) price change was +8.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.38%. For the same industry, the average monthly price growth was -11.00%, and the average quarterly price growth was -16.20%.

Reported Earning Dates

ARQT is expected to report earnings on Mar 02, 2027.

ENGN is expected to report earnings on Dec 28, 2026.

Industries' Descriptions

@Biotechnology (-3.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ARQT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARQT has been loosely correlated with XNCR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ARQT jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARQT
1D Price
Change %
ARQT100%
+6.41%
XNCR - ARQT
49%
Loosely correlated
+14.33%
PTGX - ARQT
46%
Loosely correlated
+2.23%
PTCT - ARQT
45%
Loosely correlated
+1.25%
TRDA - ARQT
42%
Loosely correlated
+7.20%
TGTX - ARQT
42%
Loosely correlated
+1.45%
More

ENGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENGN has been closely correlated with TRDA. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if ENGN jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENGN
1D Price
Change %
ENGN100%
+6.17%
TRDA - ENGN
76%
Closely correlated
+7.20%
COGT - ENGN
48%
Loosely correlated
+1.38%
PHAR - ENGN
43%
Loosely correlated
-1.24%
INSM - ENGN
42%
Loosely correlated
+5.32%
ARQT - ENGN
36%
Loosely correlated
+6.41%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HEMI41.380.62
+1.52%
Hartford Equity Premium Income ETF (HEMI)
KOMP62.720.24
+0.38%
State Street SPDR S&P Kensho New Economies Composite ETF (KOMP)
WTMY24.620.05
+0.20%
WisdomTree High Income Laddered Municipal Fund (WTMY)
BCD36.72-0.73
-1.95%
abrdn Bloomberg All Commodity Longer Dated Strategy K-1 Free ETF (BCD)
ORCU5.03-0.21
-4.01%
Direxion Daily ORCL Bull 2X ETF (ORCU)